Tempus AI vs GE HealthCare

Side-by-side comparison of AI visibility scores, market position, and capabilities

GE HealthCare leads in AI visibility (93 vs 53)
Tempus AI logo

Tempus AI

ChallengerHealthcare Tech

Precision Medicine & Diagnostics

AI precision medicine company. NASDAQ: TEM. 2025 revenue $1.27B (+83% YoY). World's largest clinical/molecular data library. Founded 2015, Chicago. 2026 guidance ~$1.59B.

AI VisibilityBeta
Overall Score
C53
Category Rank
#1 of 1
AI Consensus
54%
Trend
up
Per Platform
ChatGPT
59
Perplexity
53
Gemini
63

About

Tempus AI is an AI-powered precision medicine company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. The company has built the world's largest library of clinical and molecular data, comprising over 40 million research records including 1.5 million with matched clinical-genomic data. Tempus provides precision medicine services across oncology, cardiology, radiology, and depression through Genomics, Data and Services, and AI Applications product lines.

Full profile
GE HealthCare logo

GE HealthCare

LeaderHealthcare Tech

Enterprise

Chicago medical imaging and AI diagnostics (NASDAQ: GEHC) ~$19.7B FY2024 revenue; GE spinoff Jan 2023, Edison AI 100+ models, 4M+ installed devices, Alzheimer's PET tracer competing with Siemens Healthineers.

AI VisibilityBeta
Overall Score
A93
Category Rank
#183 of 290
AI Consensus
61%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
95
Gemini
85

About

GE HealthCare Technologies Inc. is a Chicago, Illinois-based medical technology and digital health company — publicly traded on the NASDAQ (NASDAQ: GEHC) as an S&P 500 Health Care component — designing, manufacturing, and servicing medical imaging systems, patient monitoring equipment, pharmaceutical diagnostics, and AI-powered clinical decision support software through approximately 51,000 employees in 160 countries. GE HealthCare was spun off from General Electric Company in January 2023 — one of the most significant healthcare demergers in history — and has operated as an independent public company building its own capital structure, R&D investment priorities, and operational identity separate from GE's industrial conglomerate structure. In fiscal year 2024, GE HealthCare reported revenues of approximately $19.7 billion, with its four business segments contributing: Imaging (MRI, CT, X-ray, molecular imaging — ~$9.1B), Ultrasound (~$3.0B), Patient Care Solutions (monitoring, anesthesia — ~$3.6B), and Pharmaceutical Diagnostics (PET/SPECT contrast agents — ~$2.6B). CEO Peter Arduini has prioritized accelerating GE HealthCare's AI integration across its imaging portfolio — the Edison AI platform (100+ AI models cleared or in development for radiology workflows) embeds AI-assisted detection, workflow optimization, and image quality enhancement into GE HealthCare scanners, positioning the company as a digital health platform rather than a hardware manufacturer.

Full profile

AI Visibility Head-to-Head

53
Overall Score
93
#1
Category Rank
#183
54
AI Consensus
61
up
Trend
stable
59
ChatGPT
99
53
Perplexity
95
63
Gemini
85
44
Claude
84
49
Grok
89

Key Details

Category
Precision Medicine & Diagnostics
Enterprise
Tier
Challenger
Leader
Entity Type
company
company

Capabilities & Ecosystem

Capabilities

Only Tempus AI
Precision Medicine & Diagnostics

Integrations

Only Tempus AI
Tempus AI is classified as company. GE HealthCare is classified as company (part of GE Aerospace).

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.